N-DESPROPYL GAMITHROMYCIN
UNII G9KW86B5ML

Substance Identification & Data

This profile provides standardized clinical and technical data for N-despropyl Gamithromycin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) G9KW86B5ML.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 145388-07-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

G9KW86B5ML

CAS Registry Number

145388-07-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

N-DESPROPYL GAMITHROMYCIN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C37H70N2O12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RECSSHHDKCPKFK-IJRXGBMOSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

9853428

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O([C@H]1[C@H](C)[C@@H](O[C@]2([C@H](O)[C@@H](N(C)C)C[C@@H](C)O2)[H])[C@](C)(O)C[C@@H](C)NC[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)[C@H]3C[C@](OC)(C)[C@@H](O)[C@H](C)O3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for N-despropyl Gamithromycin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

N-DESPROPYL GAMITHROMYCIN

Systematic Nomenclature

(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-11-(((2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL)OXY)-2-ETHYL-3,4,10-TRIHYDROXY-13-(((2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLTETRAHYDRO-2H-PYRAN-2-YL)OXY)-3,5,8,10,12,14-HEXAMETHYL-1-OXA-7-AZACYCLOPENTADECAN-15-ONE

SYS

(2R,3S,4R,5S,8R,10R,11R,12S,13S,14R)-13-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,8,10,12,14-HEXAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-1-OXA-7-AZACYCLOPENTADECAN-15-ONE

SYS

1-OXA-7-AZACYCLOPENTADECAN-15-ONE, 13-((2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL)OXY)-2-ETHYL-3,4,10-TRIHYDROXY-3,5,8,10,12,14-HEXAMETHYL-11-((3,4,6-TRIDEOXY-3-(DIMETHYLAMINO)-.BETA.-D-XYLO-HEXOPYRANOSYL)OXY)-, (2R-(2R*,3S*,4R*,5S*,8R*,10R*,11R*,12S*,13S*,14R*))-

SYS

External Clinical & Regulatory Resources

Previous UNIIG9KH0SR06F

Next UNIIG9KX9P6ZV4